Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
Family Physician
MBBS, MCPS (Family Medicine)
Internal Medicine Specialist
MBBS, MCPS Family Medicine
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Diabetologist
MBBS, MPhil Medical Biochemistry, Diploma in Herbal Medicine, Diploma in Diet and Nutrition, Certified In Food And Health (USA), Certified In Preventing Diabetese In High Risk Patients, Associate MRCP (UK)
Diabetologist
MBBS, MPhil Medical Biochemistry, Diploma in Herbal Medicine, Diploma in Diet and Nutrition, Certified In Food And Health (USA), Certified In Preventing Diabetese In High Risk Patients, Associate MRCP (UK)
General Physician
MBBS, MCPS (Family Medicine), MRCGP 1 [INT] SA
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures